Robert E. Coleman
Impact in
- Oncology top 0.01%
- Bone health and treatments
- Cancer Diagnosis and Treatment
- Orthopedics and Sports Medicine top 0.1%
- Bone health and osteoporosis research
- Bone and Joint Diseases
Papers in
- Oncology 315
- Bone health and treatments 242
- Cancer Diagnosis and Treatment 50
- Cancer Treatment and Pharmacology 48
-
- Radiopharmaceutical Chemistry and Applications 138
- Medical Imaging Techniques and Applications 36
- Co-authors
- Allan Lipton (41 shared papers)Janet E. Brown (47 shared papers)Ingunn Holen (36 shared papers)Richard J. Cook (29 shared papers)Peyman Hadji (16 shared papers)Helen Neville-Webbe (14 shared papers)Anthony Howell (10 shared papers)Pierre Major (15 shared papers)
- Journals
- Journal of Clinical Oncology (49 papers)Annals of Oncology (30 papers)Cancer Treatment Reviews (26 papers)British Journal of Cancer (25 papers)European Journal of Cancer (21 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Robert E. Coleman
564 papers receiving 35.1k citations
Robert E. Coleman's Hit Papers
Peers
Comparison fields: 5 of 190
- Oncology 19.3k
- Orthopedics and Sports Medicine 3.1k
- Radiology, Nuclear Medicine and Imaging 8.2k
- Pulmonary and Respiratory Medicine 6.6k
- Cancer Research 2.6k
Countries citing papers authored by Robert E. Coleman
This map shows the geographic impact of Robert E. Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Coleman more than expected).
Fields of papers citing papers by Robert E. Coleman
This network shows the impact of papers produced by Robert E. Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Coleman. The network helps show where Robert E. Coleman may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert E. Coleman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 574 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity Hit paper breakdown → | 2006 | 1889 |
| 2 | Metastatic bone disease: clinical features, pathophysiology and treatment strategies Hit paper breakdown → | 2001 | 1521 |
| 3 | Skeletal complications of malignancy Hit paper breakdown → | 1997 | 1210 |
| 4 | Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. Hit paper breakdown → | 2002 | 723 |
| 5 | Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma Hit paper breakdown → | 2003 | 693 |
| 6 | Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study Hit paper breakdown → | 2012 | 607 |
| 7 | Pathologic fractures correlate with reduced survival in patients with malignant bone disease Hit paper breakdown → | 2007 | 523 |
| 8 | 2005 | 465 | |
| 9 | 2005 | 440 | |
| 10 | 2001 | 425 | |
| 11 | Bone health in cancer patients: ESMO Clinical Practice Guidelines Hit paper breakdown → | 2014 | 422 |
| 12 | 2006 | 382 | |
| 13 | Bone metastases Hit paper breakdown → | 2020 | 373 |
| 14 | 2007 | 358 | |
| 15 | 2007 | 335 | |
| 16 | 2003 | 325 | |
| 17 | 2004 | 320 | |
| 18 | 2008 | 317 | |
| 19 | Bone health in cancer: ESMO Clinical Practice Guidelines Hit paper breakdown → | 2020 | 309 |
| 20 | Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. | 2001 | 309 |
About Robert E. Coleman
Robert E. Coleman is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Surgery and Cancer Research, having authored 574 papers that have together received 36.6k indexed citations. Recurring topics across this work include Bone health and treatments (242 papers), Radiopharmaceutical Chemistry and Applications (138 papers), Cancer Diagnosis and Treatment (50 papers), Cancer Treatment and Pharmacology (48 papers), Prostate Cancer Treatment and Research (43 papers), Management of metastatic bone disease (40 papers), Medical Imaging Techniques and Applications (36 papers) and Medical Imaging and Pathology Studies (33 papers). The work is most often cited by research in Oncology (19.3k citations), Orthopedics and Sports Medicine (3.1k citations), Radiology, Nuclear Medicine and Imaging (8.2k citations), Pulmonary and Respiratory Medicine (6.6k citations) and Cancer Research (2.6k citations). Robert E. Coleman has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Allan Lipton, Janet E. Brown, Ingunn Holen, Richard J. Cook, Peyman Hadji, Helen Neville-Webbe, Anthony Howell, Pierre Major, Fred Saad and John J. Seaman. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Treatment Reviews, British Journal of Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.